Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 12-Mar-24 4:32 PM View:  | Elanco Animal Health Inc (ELAN) | 08-Mar-24 | Private Purchase | 15,000 | $16.30 | $244,500.00 | 32% 46.33K to 61.33K | |
| 04-Dec-23 5:33 PM View: | Elanco Animal Health Inc (ELAN) | 30-Nov-23 | Grant | 20,374 | -- | -- | 78% 25.96K to 46.33K | |
| 02-Dec-22 5:10 PM View: | Elanco Animal Health Inc (ELAN) | 30-Nov-22 | Grant | 18,649 | -- | -- | 255% 7.31K to 25.96K | |
| 03-Aug-22 4:44 PM View: | Novocure Ltd (NVCR) | 02-Aug-22 | Private Sale | 837 | $69.66 | $58,304.60 | (< 1%) 552.01K to 551.18K | |
| 09-Mar-22 4:48 PM View: | Novocure Ltd (NVCR) | 08-Mar-22 | Private Sale | 2,385 | $70.10 | $167,188.00 | (< 1%) 554.4K to 552.01K | |
| 02-Dec-21 5:11 PM View: | Elanco Animal Health Inc (ELAN) | 30-Nov-21 | Grant | 7,307 | -- | -- | 100% 0 to 7.31K | |
| 04-Aug-21 5:01 PM View: | Novocure Ltd (NVCR) | 02-Aug-21 | Market Sale | 995 | $149.38 | $148,631.00 | (< 1%) 555.39K to 554.4K | < 1% |
| 15-Apr-21 6:29 PM View: | Novocure Ltd (NVCR) | 13-Apr-21 | Market Sale | 95,000 | $199.55 | $18,957,400.00 | (15%) 650.39K to 555.39K | 7% |
| 02-Apr-21 4:14 PM View: | Novocure Ltd (NVCR) | 01-Apr-21 | Market Option Sale | 7,928 | $134.12 | $1,063,300.00 | (1%) 658.32K to 650.39K | < 1% |
| 02-Apr-21 4:14 PM View: | Novocure Ltd (NVCR) | 31-Mar-21 | Option Exercise | 9,259 | $125.25 | $1,159,690.00 | 1% 649.06K to 658.32K | 6% |
| 03-Aug-20 5:51 PM View: | Novocure Ltd (NVCR) | 31-Jul-20 | Market Sale | 896 | $76.39 | $68,443.60 | (< 1%) 649.96K to 649.06K | (125%) |
| 12-May-20 4:13 PM View: | Novocure Ltd (NVCR) | 11-May-20 | Market Sale | 31,332 | $63.73 | $1,996,730.00 | (5%) 681.29K to 649.96K | (170%) |
| 11-May-20 4:17 PM View: | Novocure Ltd (NVCR) | 08-May-20 | Option Exercise | 58,767 | $63.84 | $3,751,690.00 | 9% 654.43K to 713.19K | 169% |
| 11-May-20 4:17 PM View: | Novocure Ltd (NVCR) | 08-May-20 | Market Option Sale | 31,903 | $63.50 | $2,025,870.00 | (4%) 713.19K to 681.29K | (171%) |
| 11-May-20 4:17 PM View: | Novocure Ltd (NVCR) | 07-May-20 | Option Exercise | 58,768 | $64.77 | $3,806,400.00 | 9% 626.65K to 685.42K | 165% |
| 11-May-20 4:17 PM View: | Novocure Ltd (NVCR) | 07-May-20 | Market Option Sale | 30,993 | $64.74 | $2,006,520.00 | (5%) 685.42K to 654.43K | (166%) |
| 07-May-20 4:41 PM View: | Novocure Ltd (NVCR) | 06-May-20 | Option Exercise | 58,768 | $64.15 | $3,769,970.00 | 10% 597.76K to 656.53K | 168% |
| 07-May-20 4:41 PM View: | Novocure Ltd (NVCR) | 06-May-20 | Market Option Sale | 29,881 | $64.27 | $1,920,450.00 | (5%) 656.53K to 626.65K | (168%) |
| 07-May-20 4:41 PM View: | Novocure Ltd (NVCR) | 05-May-20 | Option Exercise | 58,768 | $61.40 | $3,608,360.00 | 10% 569.28K to 628.05K | 180% |
| 07-May-20 4:41 PM View: | Novocure Ltd (NVCR) | 05-May-20 | Market Option Sale | 30,283 | $62.47 | $1,891,720.00 | (5%) 628.05K to 597.76K | (175%) |
| 06-May-20 5:52 PM View: | Novocure Ltd (NVCR) | 04-May-20 | Option Exercise | 58,768 | $60.48 | $3,554,290.00 | 12% 510.51K to 569.28K | 184% |
| 10-Mar-20 4:18 PM View: | Novocure Ltd (NVCR) | 06-Mar-20 | Market Sale | 4,320 | $69.53 | $300,387.00 | (< 1%) 514.83K to 510.51K | (147%) |
| 02-Mar-20 5:13 PM View: | Novocure Ltd (NVCR) | 28-Feb-20 | Market Option Sale | 3,893 | $72.21 | $281,133.00 | (< 1%) 518.72K to 514.83K | (138%) |
| 02-Mar-20 5:13 PM View: | Novocure Ltd (NVCR) | 27-Feb-20 | Option Exercise | 9,259 | $79.45 | $735,628.00 | 2% 509.46K to 518.72K | 116% |
| 22-Jan-20 4:19 PM View: | Novocure Ltd (NVCR) | 17-Jan-20 | Market Sale (Planned) | 133,777 | $95.00 | $12,708,800.00 | (21%) 643.24K to 509.46K | (81%) |
| 26-Nov-19 4:29 PM View: | Novocure Ltd (NVCR) | 25-Nov-19 | Market Sale | 16,223 | $96.04 | $1,558,060.00 | (2%) 659.47K to 643.24K | (79%) |
| 22-Nov-19 4:22 PM View: | Novocure Ltd (NVCR) | 20-Nov-19 | Market Sale | 149,300 | $90.36 | $13,490,000.00 | (18%) 809.47K to 660.16K | (90%) |
| 22-Nov-19 4:22 PM View: | Novocure Ltd (NVCR) | 20-Nov-19 | Market Sale (Planned) | 700 | $91.01 | $63,707.00 | (< 1%) 660.16K to 659.47K | (89%) |
| 13-Nov-19 4:31 PM View: | Novocure Ltd (NVCR) | 12-Nov-19 | Market Sale | 13,218 | $81.68 | $1,079,620.00 | (2%) 822.68K to 809.47K | (111%) |
| 13-Nov-19 4:31 PM View: | Novocure Ltd (NVCR) | 11-Nov-19 | Market Sale | 29,782 | $80.11 | $2,385,780.00 | (3%) 852.47K to 822.68K | (115%) |
| 01-Aug-19 4:12 PM View: | Novocure Ltd (NVCR) | 30-Jul-19 | Grant | 6,002 | -- | -- | < 1% 846.46K to 852.47K | |
| 01-Jul-19 4:43 PM View: | Minerva Neurosciences, Inc. (NERV) | 27-Jun-19 | Market Purchase | 3,500 | $5.50 | $19,250.00 | 15% 22.61K to 26.11K | (55%) |
| 03-Jun-19 4:08 PM View: | Novocure Ltd (NVCR) | 30-May-19 | Market Sale | 48,100 | $53.07 | $2,552,520.00 | (5%) 894.56K to 846.46K | (224%) |
| 31-May-19 4:12 PM View: | Novocure Ltd (NVCR) | 29-May-19 | Market Sale | 1,900 | $53.10 | $100,880.00 | (< 1%) 896.46K to 894.56K | (224%) |
| 10-May-19 4:13 PM View: | Novocure Ltd (NVCR) | 09-May-19 | Market Sale | 31,460 | $47.37 | $1,490,390.00 | (3%) 927.92K to 896.46K | (263%) |
| 09-May-19 4:20 PM View: | Novocure Ltd (NVCR) | 08-May-19 | Option Exercise | 58,768 | $47.62 | $2,798,530.00 | 7% 901.37K to 960.14K | 261% |
| 09-May-19 4:20 PM View: | Novocure Ltd (NVCR) | 08-May-19 | Market Option Sale | 32,218 | $47.52 | $1,531,030.00 | (3%) 960.14K to 927.92K | (262%) |
| 09-May-19 4:20 PM View: | Novocure Ltd (NVCR) | 07-May-19 | Option Exercise | 58,768 | $48.92 | $2,874,930.00 | 7% 874.7K to 933.47K | 252% |
| 09-May-19 4:20 PM View: | Novocure Ltd (NVCR) | 07-May-19 | Market Option Sale | 32,098 | $47.67 | $1,530,110.00 | (3%) 933.47K to 901.37K | (261%) |
| 07-May-19 4:28 PM View: | Novocure Ltd (NVCR) | 06-May-19 | Option Exercise | 58,768 | $48.89 | $2,873,170.00 | 7% 844.97K to 903.74K | 252% |
| 07-May-19 4:28 PM View: | Novocure Ltd (NVCR) | 06-May-19 | Market Option Sale | 29,038 | $48.07 | $1,395,910.00 | (3%) 903.74K to 874.7K | (258%) |
| 06-May-19 5:48 PM View: | Novocure Ltd (NVCR) | 03-May-19 | Option Exercise | 58,768 | $44.60 | $2,621,050.00 | 7% 816.17K to 874.94K | 286% |
| 06-May-19 5:48 PM View: | Novocure Ltd (NVCR) | 03-May-19 | Market Option Sale | 29,966 | $45.21 | $1,354,640.00 | (3%) 874.94K to 844.97K | (280%) |
| 06-May-19 5:48 PM View: | Novocure Ltd (NVCR) | 02-May-19 | Option Exercise | 58,768 | $43.28 | $2,543,480.00 | 8% 757.4K to 816.17K | 297% |
| 26-Mar-19 4:24 PM View: | Novocure Ltd (NVCR) | 22-Mar-19 | Grant | 24,554 | -- | -- | 3% 918.31K to 942.86K | |
| 01-Mar-19 4:52 PM View: | Novocure Ltd (NVCR) | 28-Feb-19 | Market Option Sale | 3,097 | $53.68 | $166,247.00 | (< 1%) 921.4K to 918.31K | (220%) |
| 01-Mar-19 4:52 PM View: | Novocure Ltd (NVCR) | 27-Feb-19 | Option Exercise | 9,260 | $52.90 | $489,854.00 | 1% 912.14K to 921.4K | 225% |
| 26-Dec-18 4:43 PM View: | Minerva Neurosciences, Inc. (NERV) | 20-Dec-18 | Market Purchase | 2,000 | $6.50 | $13,000.00 | 10% 20.61K to 22.61K | (62%) |
| 12-Dec-18 5:18 PM View: | Minerva Neurosciences, Inc. (NERV) | 11-Dec-18 | Market Purchase | 4,000 | $7.95 | $31,800.00 | 24% 16.61K to 20.61K | (69%) |
| 12-Dec-18 5:18 PM View: | Minerva Neurosciences, Inc. (NERV) | 10-Dec-18 | Market Purchase | 2,000 | $8.00 | $16,000.00 | 14% 14.61K to 16.61K | (69%) |